Hope to Ditch Interferon Has Side Effects for Trials
SAN FRANCISCO – Good science, it is said, brings more questions along with its answers. And by that standard, too, the results from Pharmasset Inc.'s ELECTRON Phase II trial of PSI-7977 presented at the annual meeting of the American Association for the Study of Liver Disease (AASLD) last week were impressive.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter